The FDA recently ended emergency use authorization (EUA) for the original Pfizer and Moderna COVID-19 vaccines, amending the authorization to include only the newer bivalent vaccines. Some vaccine opponents, including several high-profile figures, have falsely claimed that the change was due to safety concerns.
Recommendation:
High Risk Read More +
The high-profile nature of this misinformation and its potential to increase vaccine hesitancy elevates its risk. Prebunking messaging may explain that bivalent vaccines provide immunity against the original COVID-19 strain and later variants, while the older monovalent vaccines protect against the original strain but don’t provide strong protection against newer COVID-19 variants. Emphasizing that the FDA ended EUA for the monovalent vaccines so that people will receive the most effective vaccine to protect against currently circulating variants is recommended, as is explaining that the change has nothing to do with the safety of the original vaccines. Fact-Checking Source(s):
About Us
Sign Up for Public Health Alerts
About Us
Learn More